| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de094784025e53546f898a3de5a5e393 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6939
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2005-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f5edf050c85e4f32652032537f2489a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_457b7cec51abb8a7a2df48522e2678ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b5a2cd5a6effd4f2ce32e9873ee62de |
| publicationDate |
2011-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7959915-B2 |
| titleOfInvention |
Inhibitors of extracellular Hsp90 |
| abstract |
The present invention describes inhibitors of extracellular Hsp90. The inhibition of extracellular Hsp90 leads to a reduction of the invasiveness of the tumor cells. Furthermore, the invention relates to the use of molecules inhibiting extracellular Hsp90 function for the manufacture of a medicament for the treatment or prevention of invasion and/or metastatic potential of cancer cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11536727-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9068987-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011150881-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10900973-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8529891-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9933434-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9328161-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9523695-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10627409-B2 |
| priorityDate |
2003-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |